Compare PTCT & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | AX |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.0B |
| IPO Year | 2006 | 2004 |
| Metric | PTCT | AX |
|---|---|---|
| Price | $56.37 | $84.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | $100.47 | ★ $117.71 |
| AVG Volume (30 Days) | ★ 939.5K | 264.8K |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | 14.13 |
| EPS | 0.34 | ★ 2.25 |
| Revenue | ★ $264,734,000.00 | $81,254,000.00 |
| Revenue This Year | N/A | $11.96 |
| Revenue Next Year | $8.29 | $9.49 |
| P/E Ratio | $171.44 | ★ $38.37 |
| Revenue Growth | ★ 36.19 | 23.51 |
| 52 Week Low | $58.15 | $78.71 |
| 52 Week High | $90.87 | $105.74 |
| Indicator | PTCT | AX |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 32.21 |
| Support Level | N/A | $82.64 |
| Resistance Level | $69.74 | $99.97 |
| Average True Range (ATR) | 2.50 | 2.62 |
| MACD | -0.78 | -0.84 |
| Stochastic Oscillator | 1.01 | 0.53 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.